Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9161 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9065 |
High Similarity |
NPD1510 |
Phase 2 |
0.9058 |
High Similarity |
NPD1607 |
Approved |
0.9051 |
High Similarity |
NPD1240 |
Approved |
0.8993 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8803 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8803 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8786 |
High Similarity |
NPD6651 |
Approved |
0.8767 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1549 |
Phase 2 |
0.8725 |
High Similarity |
NPD4380 |
Phase 2 |
0.8675 |
High Similarity |
NPD7819 |
Suspended |
0.8675 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD7075 |
Discontinued |
0.8601 |
High Similarity |
NPD2796 |
Approved |
0.8599 |
High Similarity |
NPD7473 |
Discontinued |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD7411 |
Suspended |
0.8483 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8425 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8408 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8367 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8366 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8345 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8312 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8302 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8267 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8267 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8247 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD1512 |
Approved |
0.82 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8176 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8153 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8095 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8085 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8079 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8038 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8027 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7919 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7911 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7879 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7877 |
Intermediate Similarity |
NPD943 |
Approved |
0.7847 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7831 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7806 |
Intermediate Similarity |
NPD920 |
Approved |
0.7801 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7763 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7758 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD3268 |
Approved |
0.773 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7712 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7711 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7697 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7633 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7603 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD1164 |
Approved |
0.75 |
Intermediate Similarity |
NPD4749 |
Approved |
0.75 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7447 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7439 |
Intermediate Similarity |
NPD919 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7431 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7429 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7427 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7375 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7361 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7346 |
Intermediate Similarity |
NPD37 |
Approved |
0.7324 |
Intermediate Similarity |
NPD9545 |
Approved |
0.732 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7235 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD17 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD411 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7104 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7079 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7074 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7069
|
Intermediate Similarity |
NPD6104 |
Discontinued |